All posts
10811 total · page 107 of 217

Patient safety and pharmacovigilance developments in the Indian market
India enhances patient safety through innovative pharmacovigilance.

Impact of digital marketing regulations on pharma brand awareness
New regulations reshape how pharma brands connect online.

The role of small and medium enterprises in India’s pharma exports
SMEs drive innovation and growth in India's pharma exports.

Impacts of trade agreements on pharma inputs and finished drugs
Trade agreements shape the landscape of pharmaceutical access.

Reforms allowing conditional approvals for breakthrough therapies
New reforms speed up access to innovative therapies.

India’s strategy on biosimilars and pricing comparisons with biologics
India is redefining biosimilars, balancing affordability and quality.

India’s regulatory harmonization with global standards such as ICH and WHO
India aligns its regulations with global health standards.

How pharma associations are influencing policy and regulatory decisions
Pharma associations shape critical health policies today.

Role of automation and AI in pharma manufacturing efficiency
Automation and AI are transforming pharma manufacturing efficiency.

Impact of state government pharma clusters on regional growth
State pharma clusters boost local economies and innovation.

Transparency initiatives in pricing and adverse event reporting
Increasing transparency in pricing boosts trust and safety.

Intellectual property enforcement and challenges in Indian pharma
India's pharma sector faces key hurdles in IP enforcement.

The role of corporate social responsibility in pharma sector development
Corporate social responsibility drives innovation in pharma.

Drug safety scandals in India and reforms to rebuild public trust
India faces urgent reforms to restore trust in drug safety.

The rising threat of antimicrobial resistance and Indian R&D responses
India's fight against antimicrobial resistance grows urgent.

Economic policy shifts such as tax and subsidies affecting pharma inputs
Tax changes and subsidies reshape pharmaceutical input costs.

The future of nutraceuticals and functional foods in Indian pharma portfolios
Nutraceuticals are shaping the future of Indian pharma.

Comparative performance of Indian pharma versus other emerging markets
Indian pharma shows robust growth amid global competition.

Challenges in cold chain and distribution for vaccines and biologics
Ensuring vaccine integrity through reliable cold chain logistics.

Expansion of Indian pharma into Latin American and African markets
India's pharma industry is tapping into new global markets.

How Indian companies are preparing for stricter global audits
Indian firms gear up for tougher global audit standards.

Trends in personalized medicine and genomics in Indian pharma
Indian pharma embraces personalized medicine and genomics advances.

Pharma digital transformation with blockchain and supply chain traceability
Blockchain enhances pharma supply chain transparency and security.

Regulatory changes around fixed dose combinations in India
India's new regulations reshape fixed dose combination markets.

Trends in foreign direct investment in Indian pharma and biotech
Foreign investment in India's pharma sector is booming rapidly.

Patient access programs by pharma companies and their regulatory oversight
Navigating the complexities of pharma patient access programs.

Role of blockchain in ensuring authenticity of exported pharma goods
Blockchain enhances trust in exported pharmaceutical products.

Evolving norms around ethical clinical trial recruitment in India
New guidelines reshape ethical recruitment in India's trials.

How pharma is integrating sustainability goals with business strategies
Pharma is blending sustainability with strategic growth plans.

India’s opportunity in contract research and manufacturing services
India is poised to lead in contract research and manufacturing.

The role of pharmacoeconomics in drug pricing decisions
Pharmacoeconomics shapes fair drug pricing strategies.

Government investment in biotechnology and life sciences clusters
Government funding boosts innovation in biotech sectors.

How Indian companies are navigating global patent cliffs
Indian firms are innovating to overcome global patent challenges.

Impact of global climate policies on pharma manufacturing in India
Global climate policies are reshaping India's pharma landscape.

Digital twin and smart manufacturing applications in pharma plants
Explore how digital twins enhance efficiency in pharma manufacturing.

Trends in over-the-counter medicines and regulatory changes in India
India's OTC medicine landscape is evolving rapidly.

The growth of digital therapeutics alongside pharmaceuticals
Digital therapeutics are reshaping healthcare alongside drugs.

New opportunities in veterinary pharmaceuticals for Indian exporters
Indian exporters explore rising demand in veterinary medicines.

How Indian companies are preparing for competition in gene therapy
Indian firms are innovating to lead in gene therapy advancements.

The intersection of healthcare insurance expansion and pharma demand
Insurance expansion boosts pharma demand in unexpected ways.

The role of precision oncology in India’s drug pipeline
Precision oncology is transforming India's approach to drug development.

The impact of AI regulation on pharma research and marketing in India
AI regulation is reshaping pharma research and marketing in India.

Public health campaigns and their alignment with pharma partnerships
Exploring how pharma partnerships shape public health messaging.

How Indian pharma is participating in global antimicrobial stewardship programs
Indian pharma plays a vital role in global antimicrobial efforts.

The role of pharmacovigilance hubs in strengthening India’s safety record
Pharmacovigilance hubs enhance drug safety in India.

Appointment of Dr Anita Saxena as president of AIIMS Bhubaneswar and her priorities
Dr. Anita Saxena focuses on innovation and community health.

Stay of registration of homeopaths with MMC until Bombay High Court decision, and concerns raised by IMA
Homeopaths' MMC registration on hold amid IMA concerns.

Proposal for medicine labels to include Braille, QR codes, and voice assistance for visually impaired
Enhancing medicine labels for better accessibility and safety.

Apollo Hospitals’ acquisition of IFC’s stake in AHLL and its impact on private healthcare consolidation
Apollo's buyout signals a shift in private healthcare dynamics.

Experts call for stronger cardiac rehabilitation programmes in India to reduce recurrence of heart disease
Stronger cardiac rehab programs could save lives in India.
